Co-hosts Will Brown and John Hinkle are thrilled to welcome Janice MacLennan to this episode of PharmaMarketing 411 to have a conversation about what the pharma industry can do to improve the approach to brand strategy. We talk about how Janice has made a pivot in how she approaches marketing planning - and how that is helping companies become more aligned across their entire commercial organization. Janice’s book "Brand Planning for the Pharmaceutical Industry" discusses how branding can be...

Markus Saba is Professor, Executive In Residence, at The Center for the Business of Health at UNC’s Kenen Flagler Business School, and has a wealth of experience in the pharmaceutical industry and spent 25 years with Eli Lily in numerous senior marketing leadership roles..  Hilary Gentile is the Global Chief Strategy Officer at McCann Worldwide and has experience working with a spectrum of pharma clients, as well as with health and wellness brands. In 2017, Hilary was inducted into the...

Professor Brian Smith has more than 40 years of pharmaceutical industry experience, ranging in roles from research chemist to marketing leadership, and academic research. He has advised multiple leading pharma companies on strategy - and he has "written the book" on pharma marketing with more than 300 published works, and multiple books including “Brand Therapy” “Darwin’s Medicine” and “The Future of Pharma." Link to: Brand Therapy: 15 Techniques for Creating Brand Strategy In Pharma and...

In this episode of the PharmaMarketing 411 podcast co-hosts Will Brown and John Hinkle talk with Vasanth Seshadri, Founder of The Sunny Side, a global creative agency located in Singapore. Vasanth is also the author of the book, Cultural Engineering. The Role of Brands In a Changing World. The book is a  guide to how brands, including pharma brands, can turn themselves into catalysts of cultural change. During this episode, we explore how pharma companies can develop a purposeful approach to...

Co-hosts Will Brown and John Hinkle talk about the evolving model for virtual customer engagement with Courtney Ness, founder of Field Factor Training.  Courtney is an expert in sales training and shares her insights about the evolving nature of pharmaceutical product promotion.  Connect with Courtney at LinkedIn: https://www.linkedin.com/in/courtney-ness-9a93537/

Co-hosts Will Brown and John Hinkle talk about pre-commercialization and the importance of setting the stage before launching a new product with 2 experts: Maureen Franco and Mike Hodgson. Maureen and Mike are co-founders of the marketing insights firm PREcommercial - and they have been involved with the launches of many of the top-performing pharmaceutical products over the past decade.    Introductory V.O. for every episode.  Outro V.O. Mixdown

Justin Masterson is Senior Vice President of Strategy with Seek Company, a Cincinnati-based market research firm that specializes in connecting brands to customers by gaining insights through developing customer journey maps. Co-hosts John Hinkle and Will Brown explore the customer journey mapping process, how it impacts the development of brand strategies, and how lessons learned from consumer brands can help shape best practices for pharmaceutical brand teams. 

Co-hosts John Hinkle and Will Brown have a conversation about the perils facing pharma marketers and ad agencies when it comes to establishing a brand strategy. Suzanne Goss and Martin Mannion are experts in developing strategies for all types of pharmaceutical brands and portfolios. Their insights and experience can help you think about your strategy in a new way and see if it really is setting you up to win.  In this episode, we discuss that what might be "good" for your brand, may not be...

Enrico Magnani is Italian, with a Ph.D. from Cambridge University in the U.K., and he is now serving as the General Manager of Helsinn China. If anyone knows what it will take for someone to have success in a global marketing or ex-pat role in the life science industry, Enrico is a true expert. He has worked across borders and across cultures for his entire career.  This episode is worth the listen for anyone who works with anyone in a foreign country.  Our conversation focuses on his current...

Naming a new drug is a complex process. So much so that we needed to dedicate two episodes to the topic. Co-hosts John Hinkle and Will Brown discuss the ins and outs, and the do's and don'ts when it comes to naming drugs with two specialists: Nancy Globus and Jennifer Sirop with Addison Whitney. Nancy is VP of Regulatory and Medication Safety and Jennifer is VP of Trademarks. During this 2 episode special, we have an in-depth conversation about best practices and possible landmines to avoid...

Naming a new drug is a complex process. So much so that we needed to dedicate two episodes to the topic. Co-hosts John Hinkle and Will Brown discuss the ins and outs, and the do's and don'ts when it comes to naming drugs with two specialists: Nancy Globus and Jennifer Sirop with Addison Whitney. Nancy is VP of Regulatory and Medication Safety and Jennifer is VP of Trademarks. During this 2 episode special, we have an in-depth conversation about best practices and possible landmines to avoid...

Co-hosts Will Brown and John Hinkle speak with Leo Reis,  Global and US Marketing leader at Chiesi Rare Disease Group in Boston, MA. Leo shares his unique perspectives on best practices in rare disease marketing - which can be applied by all pharma marketers. We discuss the unique problems and opportunities that marketers face in the rare disease space, and how marketing professionals can interact cross-functionally to implement strategies that go well beyond the pharma marketer's normal...

In this episode, co-hosts John Hinkle and Will Brown explore the power of a podcasting platform and discuss the 3 C's for ensuring an internal podcast series is effective and creates engagement with an internal audience for maximum impact on improving overall commercial effectiveness.  If you are interested in being a guest on this podcast or want to develop a podcast for an internal audience, we can help.  Email our team at:   [email protected]

Host Diane Petrone speaks with global healthcare leader Sara Bender, Vice President of Strategy with Silent AF at iRhythm, a company at the epicenter of healthcare diagnostic wearable technology and data science /machine learning.  Sara shares her thoughts on what it means to develop an entrepreneurial mindset and how to apply it in the healthcare landscape. 

In this episode, host John Hinkle discusses with Mike Burrows the importance of new product planning, and how to effectively perform this vital element of the commercialization process. Mike is a life science industry veteran, primarily working at GSK in multiple customer-facing roles and extensive experience developing strategic plans across the lifecycle, including responsibility for international health economics.  Mike's expertise in the commercialization process while new pharmaceutical...

In this episode, co-hosts John Hinkle and Will Brown have an in-depth conversation with long-time pharma industry veteran Clint Burrus, President of Market Access Ashfield Engage.  Clint has developed a high level of expertise focused on market access strategy - and more importantly, he knows the pathway to success and how to avoid common pitfalls when conducting marketing research with payers. 

One problem that all pharmaceutical marketers face is how to convince payers that their innovative treatment is worth paying for. In order to make a compelling argument, pharma must develop a pipeline of "real-world evidence" that demonstrates the utility of treatments and their impact on cost.  Kari Kalgrem from Premier Applied Sciences is working with the pharmaceutical industry on this important work that will help increase patient access. 

During this episode, host Diane Petrone has the pleasure of speaking with Pam Traxel , Senior VP of Alliance Development and Philanthropy at the American Cancer Society. Pam shares her experiences in the best ways to collaborate to develop a meaningful patient advocacy strategy. 

What does it take to have a collaborative relationship with a PBM or a GPO? What are the latest developments and implications related to 340B drug pricing designations? Check out our conversation with Craig Caceci VP of Trade Relations at Ascella Health to learn more about a critical customer channel.  

Rusty Rahmer is Head of Customer Experience Solutions at GSK, and a Board Director for the Digital Analytics Association. Rusty leads the implementation of multi-channel marketing strategies across. During this episode, we discuss multi-channel marketing, the importance of developing an entrepreneurial mindset, and how smaller companies may have an inherent competitive advantage over larger companies. 

Host Diane Petrone speaks with Mindy Hemcher about maximizing work performance and delivering your best every day. Mindy is with "A Game Talent Strategies" and she focuses on helping the life science industry identify top-tier human talent.  She talks about what it means to bring your "A Game" every day to maximize your performance and results. 

In this episode of the PharmaMarketing 411 podcast, host Will Brown speaks with Ted Lawson, a multi-product marketing leader at Endo Pharmaceuticals about the importance of collaboration with internal and external partners to achieve optimal results. 

In this episode of PM411, host John Hinkle speaks with Mark Glackin, Senior Vice President, Migraine Strategy at Biohaven Pharmaceuticals. We talk about his perspective on how pharma brands win in the market by staying laser-focused on patients.

Host John Hinkle speaks with Aneil about challenges and opportunities facing the pharmaceutical industry.